Fundz

Nocimed, Inc. reported raising $1.5 Million in an initial SEC Form D filing, from an offering of $3 Million

PUBLIC · ACONAug 11, 2017$1.5M of $3M raised

Amount Raised

$1.5 Million

$1.5 Million sold, per SEC Form D (first sale Aug 11, 2017)

Round Type

Seed

BroomfieldOtherBiotechnologyHealthcareHealth Care

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Aclarion that raised within 45 days of this round, from Fundz verified event records.

  • SPR Therapeutics raised $15M on September 21, 2017.
  • Azora Therapeutics, Inc. (DE) raised $40K on August 31, 2017.
  • Akadeum Life Sciences raised $1.5M on August 31, 2017.
  • DTx Pharma, Inc. raised $25K (Pre-Seed) on August 30, 2017.
  • ORTHALIGN INC raised $7.6M on August 28, 2017.
  • Precision Optics Corporation raised $250K on August 25, 2017.

Who to call at Aclarion, and when

A new round usually means Aclarion is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aclarion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aclarion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aclarion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aclarion

Location

8181 ARISTA PLACE

Broomfield, Colorado, United States

About

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aclarion raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts20 people are listed at Aclarion. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aclarion's next move

See what Strategic adds

Aclarion raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.